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Available online 9 April 2016Charcot-Marie-Tooth disease type 4C (CMT4C) is one of the commonest autosomal recessive inherited peripheral
neuropathies and is associated with mutations in the Rab11 effector, SH3TC2. Disruption of the SH3TC2–Rab11 in-
teraction is the molecular abnormality underlying this disease. However, why SH3TC2mutations cause an isolated
demyelinating neuropathy remains unanswered. Here we show that SH3TC2 is an exclusive Schwann cell protein
expressed late in myelination and is downregulated following denervation suggesting a functional role in myelin
sheath maintenance. We support our data with an evolutionary cell biological analysis showing that the SH3TC2
gene, and its paralogue SH3TC1, are derived from an ancestral homologue, the duplication of which occurred in
the common ancestor of jawed vertebrates, coincident with the appearance of Schwann cells and peripheral
axon myelination. Furthermore, we report that SH3TC2 associates with integrin-α6, suggesting that aber-
rant Rab11-dependent endocytic trafﬁcking of this critical laminin receptor in myelinated Schwann cells
is connected to the demyelination seen in affected nerves. Our study therefore highlights the inherent
evolutionary link between SH3TC2 and peripheral nerve myelination, pointing also towards a molecular
mechanism underlying the speciﬁc demyelinating neuropathy that characterizes CMT4C.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
Charcot-Marie-Tooth disease
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Peripheral neuropathy1. Introduction
Progressive degeneration of peripheral nerves is the pathological
hallmark of the Charcot-Marie-Tooth diseases (CMT), the most
common inherited neuromuscular disorder. Clinically, CMT is charac-
terized by muscle wasting and weakness, sensory loss and limb
deformities [1]. Over 80 genes have now been shown to be associated
with CMT [2], highlighting key factors that are essential for peripheral
nerve development and function.
Peripheral nerves are composed of axons and Schwann cells. Indeed,
in keeping with this anatomical dichotomy, CMT can also be classiﬁed
into ‘demyelinating’ or ‘axonal’ forms, reﬂecting the main sites of
pathology as the Schwann cell or axon, respectively [3]. Schwann cells
play vital supportive roles including the formation of myelin sheaths
required for the efﬁcient conduction of action potentials along axons.
Schwann cell myelination of axons is highly regulated and is alsoBox 129188, Abu Dhabi, United
. This is an open access article undercharacterized by the sequential segregation of ion-channels and scaf-
folding proteins to form specialized domains along the peripheral
nerve such as the node of Ranvier, juxtaparanode and the paranodal re-
gion. Disruption of these regions can lead to peripheral nerve dysfunc-
tion and a peripheral neuropathy [4].
Myelination of peripheral nerve axons by Schwann cells is depen-
dent on the expression of speciﬁc isoforms of the integrin family of
laminin receptors [5]. These integral membrane proteins are targeted
to the plasma membrane where they function as adhesion molecules
by attaching to the extracellular basal lamina. Integrin-α6 in complex
with integrin-β1 is expressed in Schwann cells early in the process of
myelination, followed later as a complex with integrin-β4, which is
critical in maintaining the structural stability of the mature myelin
sheath [6,7]. Mice lacking the α6/β4 receptor in Schwann cells display
normal myelination initially, but develop myelin instability with time.
Integrins are known to be trafﬁcked in the endocytic and secretory
pathways, and also regulate downstream intracellular signaling [8].
Speciﬁcally, integrin-α6/β4 has long been known to undergo endocytic
recycling [9], with Rab11 also shown to regulate its cell surface
expression [10].
Rab11 has also previously been linked with CMT type 4C, an
autosomal recessive demyelinating form of CMT characterized by anthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Sh3tc2 is expressed only in sciatic nerve. A.Western blot of a panel of rat tissue lysates to determine endogenous tissue expression of Sh3tc2. A cell lysate fromHeLa cells transiently
expressing GFP–Sh3tc2 was used as a positive control and tubulin used to compare protein loading between tissues. Note that GFP–Sh3tc2 transiently expressed in HeLa cells is easily
detected despite the relatively low concentration of tubulin compared to the rat tissues. B. Western blot of rat sciatic nerve lysate to determine endogenous expression of Sh3tc2. Rat
sciatic nerve lysate was prepared as in A by homogenization in lysis buffer containing 1% Ipegal, 0.5% deoxycholate and 0.1% SDS before centrifugation. The remaining insoluble pellet
was dissolved in 8 M Urea. Endogenous Sh3tc2 was found only in the detergent-insoluble pellet (marked ‘+’) with no Sh3tc2 detected in the absence of 8 M Urea (marked ‘−’). A cell
lysate from HeLa cells transiently expressing GFP–Sh3tc2 was used as a positive control.
1280 S. Vijay et al. / Biochimica et Biophysica Acta 1862 (2016) 1279–1290early-onset neuropathy, with scoliosis as a prominent clinical feature
[11]. The disease is associatedwithmutations in SH3TC2, which encodes
a predicted 144 kDa protein containing two N-terminal SH3 domains
and at least six C-terminal tetratricopeptide repeat motifs (TPR). Both
types of domain are thought to mediate protein–protein interactions.
Interestingly, mutations in SH3TC2 were the ﬁrst mutations to be de-
scribed following the application of next generation sequencing tech-
nologies to a previously undiagnosed family with a recessive form of
CMT [12]. Previously, we and others have shown that epitope-tagged
SH3TC2 targets to intracellular membranes [13–15]. Speciﬁcally, we re-
ported that SH3TC2 taggedwith green ﬂuorescent protein (GFP) targets
to the endocytic recycling compartment and is a Rab11 effector that
affects the endocytic recycling of transferrin receptors (TfR) when
expressed in HeLa cells. Moreover, all reported CMT4C-associated path-
ogenic mutations in SH3TC2 led to loss of intracellular targeting, loss of
Rab11 binding, and loss of function on the endocytic recycling pathway.
This led us to propose that disruption of the SH3TC2–Rab11 interaction
is the fundamental molecular abnormality that underlies CMT4C [13].
Nevertheless, it remains unclear why mutations in SH3TC2 lead exclu-
sively to a demyelinating peripheral neuropathy.
No study has yet to deﬁnitively describe where and when the
SH3TC2 protein is expressed in humans or mice. Establishing the
expression pattern of the endogenous protein is therefore vital both to
understand whymutations in SH3TC2 lead speciﬁcally to a demyelinat-
ing peripheral neuropathy and also to devise potential therapeutic
strategies for this and other subtypes of CMT. In addition, which mem-
brane cargo proteins require the presence of SH3TC2 remains unclear.
We now report that SH3TC2 is found exclusively in myelinating
Schwann cells, and is expressed late during myelination. Further-
more, SH3TC2 is rapidly downregulated following denervation. To
better understand the signiﬁcance of this dynamic expression
pattern, we also conducted a comprehensive evolutionary study ofFig. 2. Sh3tc2 is expressed in Schwann cells. A. Immunoﬂuorescence studies of teased rat scia
sciatic nerve with Sh3tc2 (green) displaying crescent-shaped staining distinct from axonal tub
right includes nuclei stained with 4′-6-diamidino-2-phenylindole (DAPI). The lower panel sh
for Sh3tc2 (green) and the Schwann cell cytoplasmic marker, S100 (red) with a merged imag
Cajal bands, which are Schwann cell cytoplasmic channels that run longitudinally along axo
20 μm. B. Three dimensional render of confocal z stacks of teased rat sciatic nerve ﬁbers staine
that Sh3tc2 is found in Schwann cell cytoplasm abutting compact myelin, as indicated by M
confocal microscopy. Sh3tc2 is shown in the left panel and endogenous marker proteins are
endogenous protein (red) are shown on the right. The ﬁgure shows that Sh3tc2 is found in Sc
Schmidt–Lanterman incisures (Actin), the paranode (CASPR) or the node of Ranvier (Nav). S
denotes 10 μm.the SH3TC2 gene and its uncharacterized paralogue, SH3TC1, which
supports the hypothesis that SH3TC2 is a key protein whose
evolutionary appearance coincides with that of Schwann cells and
myelination of peripheral axons. Furthermore, we report that
SH3TC2 associates with the laminin receptor, integrin-α6, providing
a mechanistic link between SH3TC2 and the structural maintenance
of the myelin sheath. Given that SH3TC2 is expressed late in the
process of myelination, our work also identiﬁes a potential temporal
window for future therapeutic intervention applicable to patients
diagnosed with CMT4C.
2. Materials and methods
2.1. Reagents and cell culture
Antibodies used during this study include: rabbit anti-SH3TC2
(Abcam) (Figs 1, 2, 3 and 4), mouse anti-S100 (Abcam), mouse anti-
Caspr (Abcam), mouse anti-myelin basic protein (Abcam), mouse
anti-α-tubulin (AA4.3, DSHB [16]), mouse anti-beta III tubulin
(Abcam), goat anti-EF2 (Santa Cruz), rabbit anti-GAPDH (Cell Signal-
ing),mouse anti-sodium channel (Sigma), rabbit anti-p75NGF receptor
(Abcam), Rabbit anti-Krox-20 (Covance), mouse anti-GFP (Roche),
mouse anti-myc (Cell Signaling), rat anti-ITGA6 (Biolegend), mouse
anti-LAMP1 (H4A3, August, J.T./Hildreth, J.E.K., DSHB), Alexa Fluor 568
phalloidin (Invitrogen), Alexa Fluor 488- and Alexa Fluor 568-
conjugated goat anti-rabbit, anti-mouse, anti-rat and Alexa Fluor 488-
conjugated donkey anti-rabbit and Alexa Fluor 555-conjugated donkey
anti-goat secondary antibodies (Invitrogen). A rabbit polyclonal anti-
body (2058) was also generated against residues 350 to 500 of human
SH3TC2 (Eurogentec, Belgium) and afﬁnity-puriﬁed (Fig. 7). HRP-
conjugated goat anti-rabbit, goat anti-mouse, goat anti-rat and
donkey anti-goat antibodies were used as secondary antibodies fortic nerves visualized by confocal microscopy. The top panel shows a transverse section of
ulin (red), conﬁrming that Sh3tc2 is expressed in Schwann cells. A merged image on the
ows a 3 dimensional render of confocal z stacks of a rat sciatic nerve teased ﬁber stained
e seen on the right (Volocity 6.2, PerkinElmer). The resulting images are reminiscent of
ns and are critical in maintaining the integrity of the myelin sheath. Scale bars denote
d for Sh3tc2 (green), MBP (myelin basic protein, red) and DAPI (blue). The ﬁgure shows
BP. C. Colocalization immunoﬂuorescence studies of rat sciatic nerve teased ﬁbers by
shown in the middle panel. Merged images containing Sh3tc2 (green) and the indicated
hwann cell cytoplasm abutting compact myelin, as indicated by MBP, but is not found in
cale bars denote 20 μm apart from lowest panels showing Nav staining where scale bar
1281S. Vijay et al. / Biochimica et Biophysica Acta 1862 (2016) 1279–1290western blotting (Sigma-Aldrich). Protein bands separated by SDS-
PAGE and transferred to nitrocellulose membranes were detected
using WesternBright ECL Western blotting detection kit (Advansta,
CA, USA). Supersignal West Femto (Thermo Fisher) was used for detec-
tion of integrin-α6 expression in cell lysates.A
B Sh3tc2
with DAPI
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1282 S. Vijay et al. / Biochimica et Biophysica Acta 1862 (2016) 1279–1290Iowa, USA) and restriction free cloning [17,18] into pEGFP-C1 vector
(Clontech). YFP-SH3TC1 was purchased from Source Bioscience
(Cambridge, UK). DNA constructs were sequenced and validated by
Source Bioscience (Cambridge, UK).
HeLaM cells were grown at 37 °C in RPMI (Sigma-Aldrich) contain-
ing 10% FCS and 2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml
streptomycin in a 5% CO2 humidiﬁed atmosphere. HeLa cells were
transfected using polyethylenimine (Polysciences, PA, USA). RPE cells
were cultured at 37 °C in DMEM:Ham's F-12 (50:50) (Sigma-Aldrich),
10% FCS, 2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml strepto-
mycin in a 5% CO2 humidiﬁed atmosphere.
Schwann cells (SCs) were cultured according to a modiﬁed protocol
from Kaewkhaw et al. [19]. Sciatic nerves were dissected from adult rats
and SCs were allowed to dedifferentiate in DMEM supplemented with
10% FCS and 100 U/ml penicillin and 100 μg/ml streptomycin for ﬁve
days. Epineurium and perineurium were removed and the tissue was
digested in dispase and collagenase. The cells were seeded on PDL/lami-
nin coated dishes in DMEM/D-valine (PAA laboratories) supplemented
with 10% FCS, 1% penicillin and streptomycin, bovine pituitary extract,
forskolin, 1% N2 supplement and 10 ng/ml neuregulin. The media was
supplemented with 5 mM cyclic AMP to induce chemical myelination.
2.2. Immunohistochemistry of Sciatic Nerves
Sciatic nerves were dissected from rats and immersion-ﬁxed in 4%
paraformaldehyde (PFA) (w/v) for 30 min. The nerves were stored in
PBS overnight. Epineurium and perineurium were removed and
individual ﬁbers were teased on charged glass slides (Superfrost plus,
Fisher scientiﬁc), air dried and stored at −80 °C. The teased ﬁbers
were then treated with ice-cold methanol for 10 min and rehydrated
before immunostaining. For cross-sections, ﬁxed nerves were
cryoprotected in 30% sucrose (w/v) in PBS and embedded in optimal
cutting temperature compound. 10 μm sections were cut using a
cryostat; air dried and stored at−80 °C. Tissues/cells were blocked for
30min in PBS with 10% fetal calf serum, 10mMglycine and 3mM sodi-
um azide at room temperature. The tissues were incubated with
primary antibodies overnight at 4 °C and secondary antibodies for 1 h
at RT. Wide-ﬁeld ﬂuorescent images were obtained using a Zeiss
Axioplan Fluorescent Microscope and confocal images were obtained
using Zeiss LSM510 META and Zeiss LSM880 confocal microscopes
(Carl Zeiss). Data obtained from the confocal microscopes were ana-
lyzed using Zeiss LSM and ZEN software (Carl Zeiss), and Volocity
(PerkinElmer).
2.3. Protein extraction for western blotting
Tissues were homogenized in lysis buffer (50 mM Tris–HCl pH 8,
150 mM NaCl, 0.5 mM EDTA, 1% Igepal, 0.5% deoxycholate, 0.1% SDS
and Complete protease inhibitors (Roche, UK)) at 4 °C. The lysates
were then brieﬂy sonicated at 4 °C before centrifugation for 30 min at
21,000 ×g and the resulting supernatant boiled in SDS-sample buffer
(200 mM Tris–HCl pH 6.8, 30% glycerol, 2.4 M 2-mercaptoethanol,
0.1% SDS, 0.25% bromophenol blue (w/v)). For sciatic nerves, a visible
detergent-insoluble pellet was obtained in addition to a detergent-
soluble fraction and the pellet was further processed by dissolving in
8 M Urea before boiling in sample buffer. Proteins were separated by
SDS-PAGE and transferred to nitrocellulose membranes by wet or
semi-dry electrotransfer. Equal loading of protein per lanewas achieved
following relative protein concentration determination of Coomassie-
stained protein lysates using a LI-COR Odyssey Quantitative Scanning
System (LI-COR Biosciences) [20].
2.4. Comparative genomics
Complete predicted proteome data derived from genome
databases for the following taxa were downloaded from the NationalCenter for Biotechnology Information (NCBI) or the joint genome insti-
tute (JGI) including: Homo sapiens, Rattus norvegicus, Mus musculus,
Ornithorhynchus anatinus, Anolis carolinensis, Gallus gallus, Meleagris
gallopavo, Taeniopygia guttata, Xenopus tropicalis, Danio rerio,
Branchiostoma ﬂoridae, Ciona intestinalis, Drosophila melanogaster,
Caenorhabditis elegans, Trichoplax adhaerens, Monosiga brevicollis,
Salpingoeca sp., Capsaspora owczarzaki, Sphaeroforma arctica, Rozella
allomycis, Encephalitozoon cuniculi, Piromyces sp., Batrachochytrium
dendrobatidis, Catenaria anguillulae, Coemansia reversa, Conidiobolus
coronatus, Rhizophagus irregularis, Schizosaccharomyces pombe, Saccha-
romyces cerevisiae, Cryptococcus neoformans, Nematostella vectensis and
Callorhinchus milii. Additionally, data were downloaded from ensembl
(Latimeria chalumnae, Petromyzon marinus, Amphimedon queenslandica,
and Takifugu rubripes) and the Broad institute (Thecamonas trahens,
Fonticula alba, Nosema ceranae,Mortierella verticillata, Rhizopus delemar,
Neurospora crassa, and Ustilago maydis).
The H. sapiens sequences of SH3TC1 (NP_061859.3) and SH3TC2
(NP_078853.2) were used as starting queries. Initial searches were
undertaken into the respective organismal databaseswith these queries
using the basic local alignment search tool (BLAST) performed locally.
The resulting potential homologues were listed from most similar to
least similar and ranked by E-value. Results with an E-value equal to
or greater than 0.05 were regarded as a negative hit and not subjected
to further analysis. For increased sensitivity, the search process was re-
peated using HMMer (http://www.hmmer.org), again using the above
human sequences as starting queries and keeping a cut-off e-value of
0.05 as a candidate for a putative positive hit. In all cases, putative
homologues were subjected to reciprocal BLAST analysis and used as
queries into the downloaded H. sapiens predicted proteome. Proteins
were deemed as legitimate orthologues if they retrieved the initial
human query sequences or a named version thereof with an e-value
of 0.05 or lower.
In order to further search for SH3TC genes in the crucial sampling
point of the C.milii genome, searcheswere undertaken of the nucleotide
data available from this taxon, downloaded fromNCBI. BLASTx searches
using the aboveH. sapiensproteins as querieswere undertaken, yielding
hits on nucleotide scaffolds to open reading frames (ORFs) correspond-
ing to an unknown C. milii protein. The conceptual protein sequence
was obtained bymanual in silico removal of introns, yielding the longest
possible ORF that showed homology to the SH3TC genes across its entire
length.2.5. Phylogenetic analysis
All sequences identiﬁed as SH3TC homologues (listed by accession
number, ﬁgure designation and abbreviation in Table S1) were aligned
using MUSCLE [21]. Multiple sequence alignments were assessed by
eye using Mesquite v2.75 and only regions of unambiguous homology
were retained for phylogenetic analysis. ProtTest v.3.3 [22,23] was
used to assess the most appropriate model of sequence evolution.
Phylogenetic trees generated using PhyloBayes v1.5a [24] and RAxML
v8.0.24 [25], bootstrapped with 100 pseudoreplicates. RAxML consen-
sus trees were produced using the consense program from the Phylip
package v3.695 [26]. Phylogenetic trees were viewed using FigTree
v1.4, and exported to produce ﬁnal ﬁgures in Adobe Illustrator CS4.
Initial analyses of a 28 taxon, 1200 position matrix, run using a model
of PROTGAMMAIJTTF for RAxML and LG for PhyloBayes, clearly showed
that the duplication of SH3TC into SH3TC1 and SH3TC2 occurredprior to
the speciation of jawed ﬁsh, with the three identiﬁed C. milii sequences
robustlywithin the SH3TC1 clade (see Supplementary Fig. 6). Due to the
branch length of the manually predicted C. milii SCH3TC1-c sequence,
the analysis was repeated (run under a PROTGAMMAJTTF model for
RAxML and an LG model for PhyloBayes) with the sequence excluded
(Fig. 6B), yielding a dataset of 27 taxa and 1125 positions. All alignments
are available upon request.
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RPE cells stably expressing either BirA or BirA-SH3TC2were generat-
ed using the pLXIN retroviral system (Clontech) as previously described
[27] and incubated with 50μM biotin (Sigma-Aldrich) for 24 h at 37 °C.
Cells were then scraped into ice-cold PBS, pelleted and washed twice
with PBS. Cell lysis was performed by resuspension in lysis buffer
(50 mM Tris–HCl pH 7.4, 150 mM NaCl, 1% Ipegal, 0.5% sodium
deoxycholate, 1 mM EDTA, 0.1% SDS and Complete protease inhibitor
(Roche, UK)) followed by gently passing the lysate through a 25G nee-
dle. The lysates were then incubated on ice for 10min before sonication
and centrifugation at 20,000 ×g for 15 min. Following an overnight
incubation of the lysate with streptavidin beads (Thermo Scientiﬁc,
USA) at 4 °C, the beads were washed with lysis buffer, TBS (50 mM
Tris–HCl pH 7.4, 150 mM NaCl) and ﬁnally with 50 mM ammoniumbicarbonate. 50 mM ammonium bicarbonate supplemented with
10 mM DTT was then added to the beads and heated for 30 min at
56 °C followed by the addition of 50 mM iodoacetamide and further
incubation at room temperature in the dark. The beads were washed
twice with 50 mM ammonium bicarbonate before incubation with
1 μg of trypsin (Roche, UK) in 50mMammoniumbicarbonate overnight
at 37 °C. A further 1 μg of trypsin in 0.01% triﬂuoroacetic acid (TFA) was
added to the beads and incubated at 37 °C for 2 h before centrifugation
at 300 × g for 5 min. The supernatant and two further washes contain-
ing the tryptic peptides were transferred to a fresh tube and spun at
20,000 ×g for 10 min to remove insoluble material. The peptides were
then transferred to a fresh tube and dried in a vacuum centrifuge. The
dried samples were re-suspended in 20 μl MS solvent (3 % MeCN, 0.1
% TFA) for analysis by LC–MSMSusing anOrbitrapXL (Thermo) coupled
to a nanoAcquity UHPLC (Waters). Peptides were eluted by a gradient
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spectra were acquired in the Orbitrap between 300 and 2000 m/z, and
MS/MS spectra were acquired in the LTQ in a top6 DDA fashion for
ions over 1000 counts. Data was processed in MaxQuant 1.5.0.12.2.7. Immunoprecipitation
RPE cells stably expressing either BirA alone or BirA-SH3TC2 were
scraped into a small volume of ice-cold lysis buffer (20 mM HEPES
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Ipegal and Complete protease
inhibitors (Roche, UK)) and incubated on ice for 30 min. The lysates
were then sheared by passing the solution through a 23G needle before
centrifugation at 20,000 ×g for 30 min. Lysates were precleared by
incubating with protein A Sepharose beads (GE Healthcare, UK) for
1 h at 4 °C with gentle agitation. The precleared lysates were then incu-
bated with anti-SH3TC2 antibody (2058) overnight at 4 °C with gentle
agitation. Fresh protein A Sepharose beads were then added and
incubated at 4 °C for 1 h. The beads were spun at low speed andwashed
thrice with lysis buffer and thrice with PBS. Proteins were extracted by
the addition of SDS sample buffer to the beads and incubation at 65 °C
for 15 min. Extracted proteins were separated by SDS-PAGE before
transfer to nitrocellulose membranes for western blotting.2.8. Duolink proximity ligation assay
The Duolink Proximity Ligation Assay (PLA) (Sigma-Aldrich) was
performed according to the manufacturer's guidelines. In brief, cells
were plated onto glass coverslips before ﬁxation with 4% PFA (w/v) at
37 °C for 10 min. Cells were blocked with blocking solution for 30 min
before incubation with primary antibodies overnight at room tempera-
ture. Following washing, the cells were incubated with PLA probes for
1 h at 37 °C, washed twice, before incubating with ligase solution for
30min at 37 °C. A further twowasheswere performed before signal am-
pliﬁcation by incubating with polymerase solution for 100 min at 37 °C
in the dark. The cells were thenwashed before mounting on glass slides
and analyzed using a Zeiss LSM880 confocal microscope.3. Results
3.1. Sh3tc2 is expressed exclusively in Schwann cells
Having validated and veriﬁed a commercially-available anti-SH3TC2
antibody along with an afﬁnity-puriﬁed antibody raised in rabbits
towards residues 350–500 of human SH3TC2 (Supplementary Fig. 1A,
B, C, D), we ﬁrst asked which tissues contain endogenous Sh3tc2. By
1285S. Vijay et al. / Biochimica et Biophysica Acta 1862 (2016) 1279–1290probing a panel of lysates prepared from detergent-solubilized rat tis-
sues, including sciatic nerves, no expression of the Sh3tc2 protein was
detected as determined by immunoblotting (Fig. 1A and Supplementary
Fig. 2A). However, we noted that, in contrast to the other tissues, there
remained a visible insoluble pellet following detergent-solubilization of
sciatic nerves. Signiﬁcantly, following solubilization of this pellet from
sciatic nerves with 8 M Urea, we were able to detect the Sh3tc2 protein
by western blot (Fig. 1B). Furthermore, multiple higher molecular
weight bands were also visualized, suggesting possible oligomerization
of Sh3tc2. Importantly, direct solubilization of tissues with 8MUrea did
not result in the detection of Sh3tc2 expression (Supplementary Fig.
2C). These data suggest that Sh3tc2 is only expressed in peripheral
nerves.
To establish which peripheral nerve cell type expresses Sh3tc2, we
used immunohistochemistry to visualize Sh3tc2 expression in teased
adult rat sciatic nerve ﬁbers. Fig. 2A shows that Sh3tc2 is found at the
periphery of axons, forming a crescent-shaped staining distinct from
axonal tubulin when viewed in cross-section. This indicates that
Sh3tc2 is expressed in Schwann cells. Confocal microscopic images fol-
lowing co-staining of teased sciatic nerve ﬁbers with reagents labeling
speciﬁc subcellular compartments of Schwann cells revealed that
Sh3tc2 was located adjacent to the compact myelin sheath (MBP)
(Fig. 2B, C). Sh3tc2 was not found at Schmidt–Lantermann incisures
(Actin), paranodes (CASPR) or at the nodes of Ranvier (voltage-gated
sodium channel) (Fig. 2C). A 3D render of confocal Z stacks taken of
teased nerve ﬁbers showed that Sh3tc2 colocalized with the Schwann
cell cytoplasmic marker, S100, and was present in longitudinal
Schwann cell cytoplasmic channels known as Cajal bands (Fig. 2A),
structures that are essential for the structural integrity of myelinated
peripheral nerves [28]. Sh3tc2 was not found to colocalize with the ad-
hesion molecule, L1, suggesting that Sh3tc2 is not expressed in Remak
cells (Supplementary Fig. 3). These data therefore demonstrate that
the Sh3tc2 protein is exclusively expressed in Schwann cells of mature
peripheral nerves.3.2. Sh3tc2 expression is upregulated with myelination
Histological evidence of hypomyelination in Sh3tc2 knock-out mice
cannot be detected until 56 days after birth by light microscopy,
although earlier changes have been reported using electronmicroscopy
[29]. These ﬁndings suggest that the formation of the myelin sheath
does not depend on Sh3tc2 expression. In keepingwith this hypothesis,
immunohistochemistry on teased nerveﬁbers from rats revealed no ex-
pression of Sh3tc2 at birth, in contrast to the strong expression of Sh3tc2
seen at 32 days after birth (Fig. 3A). Sh3tc2 expression was also only
weakly detected by immunoblotting of sciatic nerves taken from mice
at 0, 5, 11 and 15 days after birth, compared to the strong expression
detected in 32 day old nerves (Fig. 3B). Interestingly, the expression of
the Sh3tc2-interacting protein, Rab11, increases in parallel with
Sh3tc2, suggesting a regulated program of expression of these proteins
as myelination proceeds. These ﬁndings support a functional role for
Sh3tc2 in mature myelinated peripheral nerves.
We next focused on the expression of endogenous Sh3tc2 in pri-
mary rodent Schwann cells, puriﬁed using established methods [30].
The resulting primary Schwann cells become detached from axons
during the puriﬁcation process, with consequent reversal of the
myelination program due to the loss of the necessary axonal-derived
activating signals. We did not detect Sh3tc2 expression in puriﬁed
Schwann cells at rest. However, consistent with our previous observa-
tions, Sh3tc2 was detected following incubation of puriﬁed primary
Schwann cells with high concentrations of cAMP (known to activate
the myelination program) [30], in tandem with expression of the key
myelination transcription factor, krox-20 (Fig. 3C). These data suggest
that expression of Sh3tc2 is linked to the activation of Schwann cell
myelination.3.3. Sh3tc2 is downregulated following denervation
Following nerve injury, both myelinating and unmyelinating
Schwann cells detach from damaged axons and activate a highly
regulated signaling programme that optimizes eventual nerve repair
and re-innervation of target tissues [31]. This process, orchestrated by
the transcription factor c-jun, involves signiﬁcantmorphological chang-
es in Schwann cells and the downregulation of proteins involved in
myelination [32]. We therefore used an in vitro model of nerve injury
comparing protein expression in rat sciatic nerves immediately follow-
ing extraction (Day 0) with protein extracted after 6 days of in vitro
culture, which mirrors the ‘trans-differentiation’ of Schwann cells that
occurs with axonal degeneration in vivo (Day 6) [33,34]. As predicted
for a protein involved with myelination, Sh3tc2 was downregulated
6 days after extraction (Fig. 4A, B), in contrast to the known upregula-
tion of p75NTR neurotrophin receptor on the Schwann cell surface
following denervation.
3.4. The SH3TC2 homologue, SH3TC1, also targets to the recycling
endosome
The domain architecture of SH3TC2, containing two N-terminal SH3
domains andmultiple C-terminal TPRmotifs (Fig. 5A), is only shared by
one other protein in humans, SH3TC1. SH3TC1 is an uncharacterized
gene found on chromosome 4 and is predicted to encode a 1336
amino acid, 147 kDa protein containing one N-terminal SH3 domain
and at least seven C-terminal TPR motifs (Fig. 5A). The human SH3TC1
protein has 37% sequence identity with human SH3TC2 (Supplementa-
ry Fig. 4), pointing towards potentially similar functional roles.
Moreover, the amino acid residues associated with missense mutations
in SH3TC2 leading to CMT4C are all conserved (marked by * in Supple-
mentary Fig. 4).We therefore askedwhether SH3TC1 also targets to the
endocytic recycling compartment. Indeed, as shown in Fig. 5B, epitope-
tagged SH3TC1 targeted to the endocytic recycling compartment when
transiently expressed in HeLa cells, showing signiﬁcant colocalization
with Rab11. While supportive of the hypothesis that the SH3TC genes
encode a novel family of recycling endosome proteins, the targeting of
SH3TC1 to this organelle does not appear to be Rab11-dependent
(Supplementary Fig. 5A). Furthermore, the tissue expression pattern
of SH3TC1, compared to the exclusive expression of SH3TC2 in Schwann
cells, is yet to be determined and will require the development of
speciﬁc antibodies and reagents.
3.5. SH3TC2 evolved in conjunction with the evolutionary appearance of
Schwann cells and peripheral nerve myelination
The exclusive expression of Sh3tc2 in myelinating Schwann cells
points to a very specialized function and lends support to the hypothesis
that SH3TC2 and Schwann cells might have co-evolved. Schwann
cells are derived from the neural crest, a specialized population of
multipotent migratory embryonic cells exclusive to vertebrates [35].
Furthermore, the myelination of axons by glia such as Schwann cells is
also a relatively recent evolutionary development, appearing ﬁrst in
jawed vertebrates. The resulting energy-efﬁcient and fast conduction
of action potentials across signiﬁcant distances associated with
myelination is thought to have had obvious competitive advantages
[36]. We therefore carried out a comprehensive evolutionary study of
the SH3TC2 gene, taking advantage of the extensive taxon sampling of
genomic data now available for animals. Using this approach, we
found that the SH3TC2 gene is present in taxa from humans to bony
ﬁsh (Actinopterygii), lending substantial support to our hypothesis
that the SH3TC2 gene emerged at the same time as Schwann cell-
mediated peripheral nerve myelination (Fig. 6A and Supplementary
Fig. 6).
Further analysis of available genomic data found that the SH3TC1 gene
is also present in metazoa, as basally as sharks. Additionally, single
SH3 TPR TPR TPR TPR1 1336
SH3 SH3 TPR TPR TPR TPR TPR1 1288TPR
TPR TPR TPRhuman SH3TC1
human SH3TC2
YFP-SH3TC1 myc-Rab11 Merge + DAPI
A
B
Fig. 5. SH3TC1and SH3TC2are homologues that target to the endocytic recycling compartment. A. Schematic diagrams showing thepredicted domain organization of SH3TC1andSH3TC2.
Domainswere predicted using SMART (simplemodular architecture research tool— http://smart.embl-heidelberg.de). B. Immunoﬂuorescence studies of HeLa cells transiently expressing
YFP-tagged SH3TC1 and myc-tagged Rab11. Merged images on the right show YFP-SH3TC1 (green), myc-Rab11 (red) and nuclei stained with 4′-6-diamidino-2-phenylindole (DAPI).
Scale bars denote 10 μm.
1286 S. Vijay et al. / Biochimica et Biophysica Acta 1862 (2016) 1279–1290homologues of SH3TC genes that resolve as preduplicates to either
SH3TC1 and SH3TC2 ﬁrst appears in Branchiostoma (lancelet), thought
to be representative of early chordates, and by the Hyperoatia (lampreys)
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1287S. Vijay et al. / Biochimica et Biophysica Acta 1862 (2016) 1279–12903.6. SH3TC2 associates with integrin-α6, highlighting a potential key role
for Schwann cell Rab11-dependent maintenance of peripheral nerve
myelination
All CMT4C-associated mutations in SH3TC2 disrupt the SH3TC2–
Rab11 interaction [13]. Taken together with our expression and evo-
lutionary data, we hypothesized that the maintenance of peripheral
nerve myelination must be dependent on the SH3TC2–Rab11-medi-
ated trafﬁcking of speciﬁc plasma membrane receptors in Schwann
cells. We therefore set out to identify potential SH3TC2 cargo pro-
teins that might shed light on the pathogenesis of CMT4C.Input StreptavidinPull-down
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associated protein in Retinal Pigment Epithelial cells (RPE) (Fig. 7A).
Signiﬁcantly, integrin-α6, along with other integrins expressed
in Schwann cells, has previously been shown to play an important role
in peripheral nerve myelination [5,6,44,45]. Of note, integrin-α6 was
not identiﬁed from HeLa cells and the immortalized Schwann cell
line, IFRS-1, which can be explained by the undetectable levels of
integrin-α6 expression in these cells (Supplementary Fig. 5B). The
association between SH3TC2 and integrin-α6 was veriﬁed using two
complementary techniques: co-immunoprecipitation of SH3TC2 and
integrin-α6 from RPE cells stably-expressing SH3TC2 (Fig. 7B), and the
Duolink proximity ligation assay [46] (Fig. 7C). Consistent with these
data, immunoﬂuorescence microscopy revealed a high degree of
colocalization between stably-expressed SH3TC2 and endogenous
integrin-α6 in RPE cells, being particularly concentrated at the plasma
membrane (Fig. 7D). Furthermore, endogenously expressed SH3TC2
and integrin-α6 were also found to colocalize in teased sciatic-nerve
ﬁbers (Fig. 7E).
4. Discussion
The exclusive expression of the Sh3tc2 protein in myelinating
Schwann cells explains the demyelinating peripheral neuropathy that
characterizes CMT4C. Moreover, having shown that Sh3tc2 expression
increases as myelination proceeds and, conversely, that Sh3tc2 is
downregulated following nerve injury and demyelination, our data
point strongly to a role for Sh3tc2 in the maintenance of the peripheral
nerve myelin sheath. While previous studies have also proposed that
Sh3tc2 is expressed in peripheral nerves and Schwann cells [11,29,47],
the supporting evidence has been based on RNA expression studies
and the expression of GFP protein driven by the Sh3tc2 promoter
in the Sh3tc2 knock-out mouse. Our study is the ﬁrst to characterize
the spatial along with the temporal expression pattern of the
endogenous Sh3tc2 protein in vivo. It is worth noting that the recently
published human protein atlas (www.proteinatlas.org) [48] states that
the SH3TC2 protein is expressed in a wide variety of tissues, contrary
to our data. However, the antibody used by Uhlen et al. detects a
protein band closer to 70 kDa by western blotting, rather than the
predicted 144 kDa band that we see in our study, and does not detect
exogenously-expressed SH3TC2 constructs (either by western blotting
or immunoﬂuorescence microscopy) in our hands (data not shown),
which suggests that non-speciﬁcity of the antibody is the most likely
explanation for this discrepancy in this case. Furthermore, the available
transcriptomic and RNA sequencing tissue expression databases
show inconsistent results with respect to SH3TC2 expression across 8
human and 24 mouse experiments. Nevertheless, and consistent with
our ﬁndings, SH3TC2 RNA expression was not detected in most tissues
analyzed (https://www.ebi.ac.uk/gxa/home). Additionally, Senderek
et al. have previously reported the detection of SH3TC2 RNA transcripts
in brain, spinal cord, skeletal muscle, in addition to sciatic nerve, by
northern blotting and RT-PCR [11]. However, multiple alternatively-
spliced transcripts were found to predominate in brain and spinal
cord, predicted to cause extensive truncations and resulting protein
degradation if translated, which would also be entirely consistent with
our failure to detect SH3TC2 at the protein level in these tissues.
Sh3tc2 expression is upregulated late duringmyelination, becoming
prominent at 32 days after birth, and appears to follow the upregulation
of its binding partner, Rab11. These data also complement the ﬁndings
of Arnaud et al. who previously developed and characterized an
Sh3tc2 knock-out mouse as a disease model for CMT4C [29,49]. Signiﬁ-
cantly, these mice developed normally, and neurophysiological,
ultrastructural and phenotypic abnormalities were reported only after
1 month, 2 months and 6 months, respectively. Furthermore, a recent
report revealed two cis-acting regulatory elements upstream from the
SH3TC2 gene that are responsive to the transcription factor SOX10,
which is known to play a crucial role in peripheral nerve myelination[47]. Taken together with our data, we conclude that SH3TC2 is not
required formyelination per se but is required tomaintain the structure
and integrity of the myelin sheath once it is formed. The absence of
Sh3tc2 in thesemice (and in CMT4Cpatients) eventually leads to abnor-
malities such as widening of the node of Ranvier, a critical structure
containing a high concentration of voltage-gated sodium channels
necessary for the efﬁcient propagation of action potentials [50].
Our evolutionary data also support a speciﬁc role for SH3TC2 in
peripheral nerve myelination. Schwann cells are derived from neural
crest cells, a group of multi-potent cells closely associated with
vertebrate evolution. Furthermore, although many diverse organisms
contain nervous systems that include supporting cells analogous to
glia, the existence of Schwann-cell mediated myelinated axons occurs
only with the emergence of the gnathostomata [37]. By searching the
current diversity of animal genome DNA databases, we found clear ho-
mologues to SH3TC2 only in bony vertebrates, consistent with the ﬁnd-
ings of Senderek et al. (who had access to only a limited number of
completed genomes at that time) [11]. Interestingly, and despite
possessing fully formed peripheral nerve myelin, we failed to ﬁnd a
clear orthologue of the SH3TC2 gene in cartilaginous vertebrates such
as sharks. This could be explained by incomplete coverage in the
currently available shark genome or, as a highly speculative but intrigu-
ing alternative, may suggest that these species might have evolved an
alternative strategy that could include the use of one of the three
SH3TC1 genes that we identiﬁed (Fig. 6B and Supplementary Fig. 6), to
maintain the integrity of their peripheral nerve myelin sheaths.
In contrast to SH3TC2,manydemyelinatingCMT-associated proteins
that are known or predicted to play a role in intracellular membrane
trafﬁcking, such as LITAF, MTMR2/MTMR13, NDRG1, FIG4, and DNM2,
arewidely expressed in different tissues [51–55] and are also evolution-
arily conserved in species that predate the emergence of chordates
[56–60]. These proteins therefore possess diverse general membrane
trafﬁcking functions applicable across different tissues but must also
have critical non-redundant roles in maintaining peripheral nerve
function.
Our data, taken together with information from genome databases,
strongly suggest that SH3TC2 evolved speciﬁcally to play a unique,
Rab11-dependent role that is exclusive to myelinated Schwann cells.
Moreover, we can also conclude that the structural integrity of the
myelin sheath is dependent on the expression of SH3TC2 in Schwann
cells along with its ability to associate with Rab11. This leads to the
hypothesis that the maintenance of peripheral nerve myelination
must be reliant on the SH3TC2/Rab11-mediated intracellular trafﬁcking
of a speciﬁc Schwann cell cargo. Here, we show that SH3TC2 associates
with integrin-α6, a crucial laminin receptor expressed on thebasolateral
surface of Schwann cells and known to play an important role in periph-
eral nerve myelination [7]. Indeed, integrin-α6 in conjunction with
integrin-β4 is expressed later in myelination, similarly to SH3TC2, and
loss of this heterodimeric laminin receptor is associated with
progressive myelin structural instability [6]. Integrins, including the
integrin-α6/β4 heterodimer, are known to undergo Rab11-dependent
endocytic recycling, which leads to the intriguing possibility that
SH3TC2 mediates the Rab11-dependent trafﬁcking of integrin-α6/β4
in myelinating Schwann cells in vivo. These data lead us therefore to
speculate that loss of the SH3TC2–Rab11 interaction, as a consequence
of CMT4C-associated pathogenic mutations, could cause aberrant
endocytic recycling of integrin-α6/β4, leading to the loss of attachment
between the Schwann cell abaxonal membrane and the extracellular
matrix, resulting in the destabilization of themyelin sheath and, eventu-
ally, the demyelinating peripheral neuropathy that characterizes
CMT4C. Nevertheless, how SH3TC2 and integrin-α6 interact precisely
at the molecular level, and whether SH3TC2 also regulates the trafﬁck-
ing of other Schwann cell cargo proteins, has yet to be determined.
Furthermore, a key unanswered question is whether the pathological
mechanisms underlying more than one subtype of demyelinating CMT
can be linked to the endocytic trafﬁcking of a common Schwann cell
1289S. Vijay et al. / Biochimica et Biophysica Acta 1862 (2016) 1279–1290cargo, such as integrin-α6/β4, which would have profound implications
for the developments of future treatments.
5. Conclusions
We conclude that SH3TC2 is an exclusive and speciﬁc Schwann cell
protein that is expressed late in peripheral nerve myelination, pointing
to a key role in maintaining the structural integrity of peripheral nerve
myelin sheaths. We speculate that this function is mediated through
an interaction between SH3TC2 and integrin-α6 which regulates the
Rab11-dependent endocytic recycling of this key Schwann cell surface
receptor. Our expression data help explain why mutations in SH3TC2,
previously shown to inhibit Rab11 binding, lead speciﬁcally to the
demyelinating peripheral neuropathy that characterizes CMT4C. In the
absence of any current treatments and the relatively late expression of
SH3TC2 in myelination, our ﬁndings therefore highlight a potential
temporal therapeutic window where future treatments might be
targeted.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2016.04.003.
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